| Income Statement |
| Total Revenue | 21.69M |
|
| Revenues (USD) | 21.69M |
| Cost of Revenue | 6.94M |
| Gross Profit | 14.75M |
| Operating Expenses | 32.03M |
| Research and Development Expense | 9.46M |
| Selling, General and Administrative Expense | 22.57M |
| Operating Income | -17.28M |
| Interest Expense | 1.67M |
| Income Tax Expense | 253.00K |
| Net Income | -19.32M |
| Net Income Common Stock | -19.32M |
| Net Income Common Stock (USD) | -19.32M |
| Consolidated Income | -19.32M |
| Earnings per Basic Share | -0.27 |
| Earnings per Basic Share (USD) | -0.27 |
| Earnings per Diluted Share | -0.27 |
| Earning Before Interest & Taxes (EBIT) | -17.40M |
| Earning Before Interest & Taxes (USD) | -17.40M |
| Weighted Average Shares | 68.49M |
| Balance Sheet |
| Cash and Equivalents | 65.39M |
| Cash and Equivalents (USD) | 65.39M |
| Trade and Non-Trade Receivables | 14.31M |
| Current Assets | 95.81M |
| Property, Plant & Equipment Net | 16.80M |
| Total Assets | 157.00M |
| Debt Current | 2.71M |
| Total Debt | 62.43M |
| Current Liabilities | 46.60M |
| Debt Non-Current | 59.71M |
| Total Liabilities | 111.31M |
| Accumulated Retained Earnings (Deficit) | -538.60M |
| Shareholders Equity | 45.69M |
| Shareholders Equity (USD) | 45.69M |
| Assets Non-Current | 61.18M |
| Total Debt (USD) | 62.43M |
| Deferred Revenue | 15.95M |
| Goodwill and Intangible Assets | 35.82M |
| Inventory | 7.09M |
| Liabilities Non-Current | 64.71M |
| Trade and Non-Trade Payables | 12.67M |
| Tax Assets | 1.81M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.75M |
| Net Cash Flow from Financing | 13.04M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.66M |
| Capital Expenditure | -878.00K |
| Issuance (Purchase) of Equity Shares | 14.96M |
| Issuance (Repayment) of Debt Securities | -569.00K |
| Net Cash Flow from Investing | -2.58M |
| Net Cash Flow from Operations | -15.09M |
| Share Based Compensation | 3.31M |